Liposomes are lipid microcapsules composed of an amphiphilic lipid bilayer (monolayer) and/or a series of concentric discontinuous aqueous compartments separated by a series of multiple amphiphilic bilayers. In liposome drugs, the drug is contained in liposomes. In general, water-soluble drugs are often encapsulated in the aqueous compartment, and lipophilic drugs are encapsulated in the lipid bilayer of the liposome.
LPI (LP Information)' newest research report, the “Liposome Injection Industry Forecast” looks at past sales and reviews total world Liposome Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Liposome Injection sales for 2023 through 2029. With Liposome Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liposome Injection industry.
This Insight Report provides a comprehensive analysis of the global Liposome Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liposome Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Liposome Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liposome Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liposome Injection.
The global Liposome Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Liposome Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Liposome Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Liposome Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Liposome Injection players cover CSPC, Luye Pharma, Fudan Zhangjiang, Nanjing Cisco, Qilu Pharmaceutical, Sichuan Kelun, Modern Medicine, Eudinamis and Indiamart, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Liposome Injection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Doxorubicin Hydrochloride Liposome Injection
Mitoxantrone Hydrochloride Liposome Injection
Irinotecan Hydrochloride Liposome Injection
Others
Segmentation by application
Malignant Tumor Treatment
Infection Treatment
Post-operative Pain Relief
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CSPC
Luye Pharma
Fudan Zhangjiang
Nanjing Cisco
Qilu Pharmaceutical
Sichuan Kelun
Modern Medicine
Eudinamis
Indiamart
Getwelloncology
Polymun
Key Questions Addressed in this Report
What is the 10-year outlook for the global Liposome Injection market?
What factors are driving Liposome Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Liposome Injection market opportunities vary by end market size?
How does Liposome Injection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Liposome Injection Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Liposome Injection by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Liposome Injection by Country/Region, 2018, 2022 & 2029 2.2 Liposome Injection Segment by Type 2.2.1 Doxorubicin Hydrochloride Liposome Injection 2.2.2 Mitoxantrone Hydrochloride Liposome Injection 2.2.3 Irinotecan Hydrochloride Liposome Injection 2.2.4 Others 2.3 Liposome Injection Sales by Type 2.3.1 Global Liposome Injection Sales Market Share by Type (2018-2023) 2.3.2 Global Liposome Injection Revenue and Market Share by Type (2018-2023) 2.3.3 Global Liposome Injection Sale Price by Type (2018-2023) 2.4 Liposome Injection Segment by Application 2.4.1 Malignant Tumor Treatment 2.4.2 Infection Treatment 2.4.3 Post-operative Pain Relief 2.4.4 Others 2.5 Liposome Injection Sales by Application 2.5.1 Global Liposome Injection Sale Market Share by Application (2018-2023) 2.5.2 Global Liposome Injection Revenue and Market Share by Application (2018-2023) 2.5.3 Global Liposome Injection Sale Price by Application (2018-2023) 3 Global Liposome Injection by Company 3.1 Global Liposome Injection Breakdown Data by Company 3.1.1 Global Liposome Injection Annual Sales by Company (2018-2023) 3.1.2 Global Liposome Injection Sales Market Share by Company (2018-2023) 3.2 Global Liposome Injection Annual Revenue by Company (2018-2023) 3.2.1 Global Liposome Injection Revenue by Company (2018-2023) 3.2.2 Global Liposome Injection Revenue Market Share by Company (2018-2023) 3.3 Global Liposome Injection Sale Price by Company 3.4 Key Manufacturers Liposome Injection Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Liposome Injection Product Location Distribution 3.4.2 Players Liposome Injection Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Liposome Injection by Geographic Region 4.1 World Historic Liposome Injection Market Size by Geographic Region (2018-2023) 4.1.1 Global Liposome Injection Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Liposome Injection Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Liposome Injection Market Size by Country/Region (2018-2023) 4.2.1 Global Liposome Injection Annual Sales by Country/Region (2018-2023) 4.2.2 Global Liposome Injection Annual Revenue by Country/Region (2018-2023) 4.3 Americas Liposome Injection Sales Growth 4.4 APAC Liposome Injection Sales Growth 4.5 Europe Liposome Injection Sales Growth 4.6 Middle East & Africa Liposome Injection Sales Growth 5 Americas 5.1 Americas Liposome Injection Sales by Country 5.1.1 Americas Liposome Injection Sales by Country (2018-2023) 5.1.2 Americas Liposome Injection Revenue by Country (2018-2023) 5.2 Americas Liposome Injection Sales by Type 5.3 Americas Liposome Injection Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Liposome Injection Sales by Region 6.1.1 APAC Liposome Injection Sales by Region (2018-2023) 6.1.2 APAC Liposome Injection Revenue by Region (2018-2023) 6.2 APAC Liposome Injection Sales by Type 6.3 APAC Liposome Injection Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Liposome Injection by Country 7.1.1 Europe Liposome Injection Sales by Country (2018-2023) 7.1.2 Europe Liposome Injection Revenue by Country (2018-2023) 7.2 Europe Liposome Injection Sales by Type 7.3 Europe Liposome Injection Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Liposome Injection by Country 8.1.1 Middle East & Africa Liposome Injection Sales by Country (2018-2023) 8.1.2 Middle East & Africa Liposome Injection Revenue by Country (2018-2023) 8.2 Middle East & Africa Liposome Injection Sales by Type 8.3 Middle East & Africa Liposome Injection Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Liposome Injection 10.3 Manufacturing Process Analysis of Liposome Injection 10.4 Industry Chain Structure of Liposome Injection 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Liposome Injection Distributors 11.3 Liposome Injection Customer 12 World Forecast Review for Liposome Injection by Geographic Region 12.1 Global Liposome Injection Market Size Forecast by Region 12.1.1 Global Liposome Injection Forecast by Region (2024-2029) 12.1.2 Global Liposome Injection Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Liposome Injection Forecast by Type 12.7 Global Liposome Injection Forecast by Application 13 Key Players Analysis 13.1 CSPC 13.1.1 CSPC Company Information 13.1.2 CSPC Liposome Injection Product Portfolios and Specifications 13.1.3 CSPC Liposome Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 CSPC Main Business Overview 13.1.5 CSPC Latest Developments 13.2 Luye Pharma 13.2.1 Luye Pharma Company Information 13.2.2 Luye Pharma Liposome Injection Product Portfolios and Specifications 13.2.3 Luye Pharma Liposome Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Luye Pharma Main Business Overview 13.2.5 Luye Pharma Latest Developments 13.3 Fudan Zhangjiang 13.3.1 Fudan Zhangjiang Company Information 13.3.2 Fudan Zhangjiang Liposome Injection Product Portfolios and Specifications 13.3.3 Fudan Zhangjiang Liposome Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Fudan Zhangjiang Main Business Overview 13.3.5 Fudan Zhangjiang Latest Developments 13.4 Nanjing Cisco 13.4.1 Nanjing Cisco Company Information 13.4.2 Nanjing Cisco Liposome Injection Product Portfolios and Specifications 13.4.3 Nanjing Cisco Liposome Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Nanjing Cisco Main Business Overview 13.4.5 Nanjing Cisco Latest Developments 13.5 Qilu Pharmaceutical 13.5.1 Qilu Pharmaceutical Company Information 13.5.2 Qilu Pharmaceutical Liposome Injection Product Portfolios and Specifications 13.5.3 Qilu Pharmaceutical Liposome Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Qilu Pharmaceutical Main Business Overview 13.5.5 Qilu Pharmaceutical Latest Developments 13.6 Sichuan Kelun 13.6.1 Sichuan Kelun Company Information 13.6.2 Sichuan Kelun Liposome Injection Product Portfolios and Specifications 13.6.3 Sichuan Kelun Liposome Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Sichuan Kelun Main Business Overview 13.6.5 Sichuan Kelun Latest Developments 13.7 Modern Medicine 13.7.1 Modern Medicine Company Information 13.7.2 Modern Medicine Liposome Injection Product Portfolios and Specifications 13.7.3 Modern Medicine Liposome Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Modern Medicine Main Business Overview 13.7.5 Modern Medicine Latest Developments 13.8 Eudinamis 13.8.1 Eudinamis Company Information 13.8.2 Eudinamis Liposome Injection Product Portfolios and Specifications 13.8.3 Eudinamis Liposome Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Eudinamis Main Business Overview 13.8.5 Eudinamis Latest Developments 13.9 Indiamart 13.9.1 Indiamart Company Information 13.9.2 Indiamart Liposome Injection Product Portfolios and Specifications 13.9.3 Indiamart Liposome Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Indiamart Main Business Overview 13.9.5 Indiamart Latest Developments 13.10 Getwelloncology 13.10.1 Getwelloncology Company Information 13.10.2 Getwelloncology Liposome Injection Product Portfolios and Specifications 13.10.3 Getwelloncology Liposome Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Getwelloncology Main Business Overview 13.10.5 Getwelloncology Latest Developments 13.11 Polymun 13.11.1 Polymun Company Information 13.11.2 Polymun Liposome Injection Product Portfolios and Specifications 13.11.3 Polymun Liposome Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Polymun Main Business Overview 13.11.5 Polymun Latest Developments 14 Research Findings and Conclusion